Flagellin Modulates the Function of Invariant NKT Cells From Patients With Asthma via Dendritic Cells
Invariant natural killer T (iNKT) cells play a critical role in the pathogenesis of asthma. We previously reported the association between circulating Th2-like iNKT cells and lung function in asthma patients and the suppressive effect of Toll-like receptor 5 ligand flagellin B (FlaB) on asthmatic in...
Saved in:
Published in | Allergy, asthma & immunology research Vol. 8; no. 3; pp. 206 - 215 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Korea (South)
The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease
01.05.2016
대한천식알레르기학회 |
Subjects | |
Online Access | Get full text |
ISSN | 2092-7355 2092-7363 2092-7363 |
DOI | 10.4168/aair.2016.8.3.206 |
Cover
Abstract | Invariant natural killer T (iNKT) cells play a critical role in the pathogenesis of asthma. We previously reported the association between circulating Th2-like iNKT cells and lung function in asthma patients and the suppressive effect of Toll-like receptor 5 ligand flagellin B (FlaB) on asthmatic in a mouse model. Thus, we investigated whether FlaB modulates the function of circulating iNKT cells in asthmatic patients.
Peripheral blood mononuclear cells (PBMCs) were treated with FlaB, and the secreted and intracellular cytokines of iNKT cells were evaluated by using ELISA and flow cytometry, respectively, following stimulation with α-galactosylceramide. Foxp3⁺ iNKT cells were also measured. To determine the effect of FlaB-treated dendritic cells (DCs) on iNKT cells, we co-cultured CD14⁺ monocyte-derived DCs and T cells from patients with house dust mite-sensitive asthma and analyzed intracellular cytokines in iNKT cells.
A reduction of IL-4 and IL-17 production by iNKT cells in PBMCs after FlaB treatment was alleviated following blocking of IL-10 signaling. A decrease in the frequencies of IL-4⁺ and IL-17⁺ iNKT cells by FlaB-treated DCs was reversed after blocking of IL-10 signaling. Simultaneously, an increase in Foxp3⁺ iNKT cells induced by FlaB treatment disappeared after blocking of IL-10.
FlaB may inhibit Th2- and Th17-like iNKT cells and induce Foxp3⁺ iNKT cells by DCs via an IL-10-dependent mechanism in asthmatic patients. In patients with a specific asthma phenotype associated with iNKT cells, FlaB may be an effective immunomodulator for iNKT cell-targeted immunotherapy. |
---|---|
AbstractList | Invariant natural killer T (iNKT) cells play a critical role in the pathogenesis of asthma. We previously reported the association between circulating Th2-like iNKT cells and lung function in asthma patients and the suppressive effect of Toll-like receptor 5 ligand flagellin B (FlaB) on asthmatic in a mouse model. Thus, we investigated whether FlaB modulates the function of circulating iNKT cells in asthmatic patients.
Peripheral blood mononuclear cells (PBMCs) were treated with FlaB, and the secreted and intracellular cytokines of iNKT cells were evaluated by using ELISA and flow cytometry, respectively, following stimulation with α-galactosylceramide. Foxp3⁺ iNKT cells were also measured. To determine the effect of FlaB-treated dendritic cells (DCs) on iNKT cells, we co-cultured CD14⁺ monocyte-derived DCs and T cells from patients with house dust mite-sensitive asthma and analyzed intracellular cytokines in iNKT cells.
A reduction of IL-4 and IL-17 production by iNKT cells in PBMCs after FlaB treatment was alleviated following blocking of IL-10 signaling. A decrease in the frequencies of IL-4⁺ and IL-17⁺ iNKT cells by FlaB-treated DCs was reversed after blocking of IL-10 signaling. Simultaneously, an increase in Foxp3⁺ iNKT cells induced by FlaB treatment disappeared after blocking of IL-10.
FlaB may inhibit Th2- and Th17-like iNKT cells and induce Foxp3⁺ iNKT cells by DCs via an IL-10-dependent mechanism in asthmatic patients. In patients with a specific asthma phenotype associated with iNKT cells, FlaB may be an effective immunomodulator for iNKT cell-targeted immunotherapy. Purpose: Invariant natural killer T (iNKT) cells play a critical role in the pathogenesis of asthma. We previously reported the association between circulating Th2-like iNKT cells and lung function in asthma patients and the suppressive effect of Toll-like receptor 5 ligand flagellin B (FlaB) on asthmatic in a mouse model. Thus, we investigated whether FlaB modulates the function of circulating iNKT cells in asthmatic patients. Methods: Peripheral blood mononuclear cells (PBMCs) were treated with FlaB, and the secreted and intracellular cytokines of iNKT cells were evaluated by using ELISA and flow cytometry, respectively, following stimulation with α-galactosylceramide. Foxp3+ iNKT cells were also measured. To determine the effect of FlaB-treated dendritic cells (DCs) on iNKT cells, we co-cultured CD14+ monocyte-derived DCs and T cells from patients with house dust mite-sensitive asthma and analyzed intracellular cytokines in iNKT cells. Results: A reduction of IL-4 and IL-17 production by iNKT cells in PBMCs after FlaB treatment was alleviated following blocking of IL-10 signaling. A decrease in the frequencies of IL-4+ and IL-17+ iNKT cells by FlaB-treated DCs was reversed after blocking of IL-10 signaling. Simultaneously, an increase in Foxp3+ iNKT cells induced by FlaB treatment disappeared after blocking of IL-10. Conclusions: FlaB may inhibit Th2- and Th17-like iNKT cells and induce Foxp3+ iNKT cells by DCs via an IL-10-dependent mechanism in asthmatic patients. In patients with a specific asthma phenotype associated with iNKT cells, FlaB may be an effective immunomodulator for iNKT cell-targeted immunotherapy. KCI Citation Count: 4 Purpose Invariant natural killer T (iNKT) cells play a critical role in the pathogenesis of asthma. We previously reported the association between circulating Th2-like iNKT cells and lung function in asthma patients and the suppressive effect of Toll-like receptor 5 ligand flagellin B (FlaB) on asthmatic in a mouse model. Thus, we investigated whether FlaB modulates the function of circulating iNKT cells in asthmatic patients. Methods Peripheral blood mononuclear cells (PBMCs) were treated with FlaB, and the secreted and intracellular cytokines of iNKT cells were evaluated by using ELISA and flow cytometry, respectively, following stimulation with alpha -galactosylceramide. Foxp3 super(+) iNKT cells were also measured. To determine the effect of FlaB-treated dendritic cells (DCs) on iNKT cells, we co-cultured CD14 super(+) monocyte-derived DCs and T cells from patients with house dust mite-sensitive asthma and analyzed intracellular cytokines in iNKT cells. Results A reduction of IL-4 and IL-17 production by iNKT cells in PBMCs after FlaB treatment was alleviated following blocking of IL-10 signaling. A decrease in the frequencies of IL-4 super(+) and IL-17 super(+) iNKT cells by FlaB-treated DCs was reversed after blocking of IL-10 signaling. Simultaneously, an increase in Foxp3 super(+) iNKT cells induced by FlaB treatment disappeared after blocking of IL-10. Conclusions FlaB may inhibit Th2- and Th17-like iNKT cells and induce Foxp3 super(+) iNKT cells by DCs via an IL-10-dependent mechanism in asthmatic patients. In patients with a specific asthma phenotype associated with iNKT cells, FlaB may be an effective immunomodulator for iNKT cell-targeted immunotherapy. PURPOSEInvariant natural killer T (iNKT) cells play a critical role in the pathogenesis of asthma. We previously reported the association between circulating Th2-like iNKT cells and lung function in asthma patients and the suppressive effect of Toll-like receptor 5 ligand flagellin B (FlaB) on asthmatic in a mouse model. Thus, we investigated whether FlaB modulates the function of circulating iNKT cells in asthmatic patients.METHODSPeripheral blood mononuclear cells (PBMCs) were treated with FlaB, and the secreted and intracellular cytokines of iNKT cells were evaluated by using ELISA and flow cytometry, respectively, following stimulation with α-galactosylceramide. Foxp3⁺ iNKT cells were also measured. To determine the effect of FlaB-treated dendritic cells (DCs) on iNKT cells, we co-cultured CD14⁺ monocyte-derived DCs and T cells from patients with house dust mite-sensitive asthma and analyzed intracellular cytokines in iNKT cells.RESULTSA reduction of IL-4 and IL-17 production by iNKT cells in PBMCs after FlaB treatment was alleviated following blocking of IL-10 signaling. A decrease in the frequencies of IL-4⁺ and IL-17⁺ iNKT cells by FlaB-treated DCs was reversed after blocking of IL-10 signaling. Simultaneously, an increase in Foxp3⁺ iNKT cells induced by FlaB treatment disappeared after blocking of IL-10.CONCLUSIONSFlaB may inhibit Th2- and Th17-like iNKT cells and induce Foxp3⁺ iNKT cells by DCs via an IL-10-dependent mechanism in asthmatic patients. In patients with a specific asthma phenotype associated with iNKT cells, FlaB may be an effective immunomodulator for iNKT cell-targeted immunotherapy. |
Author | Koh, Young-Il Shim, Jae-Uoong Rhee, Joon-Haeng Jeong, Ji-Ung |
AuthorAffiliation | 2 Clinical Vaccine R&D Center, Department of Microbiology, Chonnam National University Medical School, Gwangju, Korea 1 Department of Internal Medicine, Chonnam National University Medical School & Hospital, Gwangju, Korea |
AuthorAffiliation_xml | – name: 2 Clinical Vaccine R&D Center, Department of Microbiology, Chonnam National University Medical School, Gwangju, Korea – name: 1 Department of Internal Medicine, Chonnam National University Medical School & Hospital, Gwangju, Korea |
Author_xml | – sequence: 1 givenname: Jae-Uoong surname: Shim fullname: Shim, Jae-Uoong organization: Department of Internal Medicine, Chonnam National University Medical School & Hospital, Gwangju, Korea – sequence: 2 givenname: Joon-Haeng surname: Rhee fullname: Rhee, Joon-Haeng organization: Clinical Vaccine R&D Center, Department of Microbiology, Chonnam National University Medical School, Gwangju, Korea – sequence: 3 givenname: Ji-Ung surname: Jeong fullname: Jeong, Ji-Ung organization: Department of Internal Medicine, Chonnam National University Medical School & Hospital, Gwangju, Korea – sequence: 4 givenname: Young-Il surname: Koh fullname: Koh, Young-Il organization: Department of Internal Medicine, Chonnam National University Medical School & Hospital, Gwangju, Korea |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26922930$$D View this record in MEDLINE/PubMed https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002100524$$DAccess content in National Research Foundation of Korea (NRF) |
BookMark | eNqNUk2P0zAQtdAidin7A7ggH7m0-CtOckGqCoWK5UOoiKM1dZyt2cTu2k7R_nscArvAAbBkzUjz3sy8Zz9EJ847g9BjShaCyuoZgA0LRqhcVAueE3kPnTFSs3nJJT-5zYviFJ3H-IXkw6kQUjxAp0zWjNWcnCGz7uDSdJ11-K1vhg6SiTjtDV4PTifrHfYt3rgjBAsu4XdvtniV4RGvg-_xB0jWuBTxZ5v2eBnTvgd8tIBfGNcEm6ye0I_Q_Ra6aM5_xBn6tH65Xb2eX7x_tVktL-ZayCLNuS4EkRUI0VBdVG3JykqyXc31rma6kU2dtTVAWFFoY6BhVO-I1ES0WjcVlXyGnk59XWjVlbbKg_0eL726Cmr5cbtRrOAs3xliE3RwB7j5Cl2nDsH2EG4UJWp0WI0Oq9FhVSmek7H_84l0GHa9aXTWHuCOOE77veLsPs8-KlGWnJHqbsFD8NeDiUn1NupsETjjh6hoxUvOec3Zv6GlrCWtJSMZ-uTXtW73-fnMGUAngA4-xmDa_9Ja_sHRNsH4JbIy2_2F-Q1GnM5S |
CitedBy_id | crossref_primary_10_1002_hep_29140 crossref_primary_10_1016_j_coviro_2023_101330 crossref_primary_10_1007_s00213_019_5176_9 crossref_primary_10_1016_j_alit_2019_02_003 crossref_primary_10_4168_aair_2019_11_2_254 |
Cites_doi | 10.1016/j.jaci.2011.07.036 10.4049/jimmunol.181.7.4560 10.4168/aair.2012.4.5.295 10.1084/jem.20051166 10.1038/nri854 10.1038/nri1968 10.1084/jem.20071507 10.1172/JCI72308 10.4049/jimmunol.1101299 10.1007/s10875-008-9269-1 10.1056/NEJMoa053614 10.4168/aair.2014.6.3.201 10.4049/jimmunol.1000359 10.1111/j.1365-2249.2010.04151.x 10.1038/90667 10.1093/intimm/dxr040 10.1159/000330908 10.1165/rcmb.2009-0023OC 10.1056/NEJMoa064691 10.1038/nri3369 10.1016/j.molimm.2010.07.006 10.1159/000314364 10.1038/nm1770 10.1016/j.jaci.2015.07.010 10.1371/journal.pone.0097418 10.1111/j.1365-2222.2006.02639.x 10.3346/jkms.2004.19.5.640 10.1038/nm851 10.4168/aair.2014.6.5.444 10.1128/IAI.74.1.694-702.2006 10.1007/s10875-007-9138-3 10.1073/pnas.0510282103 10.4049/jimmunol.0804225 10.2217/imt.09.30 10.1016/j.vaccine.2013.06.054 10.4049/jimmunol.0903446 10.4049/jimmunol.1003043 10.1016/j.it.2006.05.003 |
ContentType | Journal Article |
Copyright | Copyright © 2016 The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease 2016 |
Copyright_xml | – notice: Copyright © 2016 The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease 2016 |
DBID | AAYXX CITATION NPM 7X8 7T5 7U7 C1K H94 5PM ADTOC UNPAY ACYCR |
DOI | 10.4168/aair.2016.8.3.206 |
DatabaseName | CrossRef PubMed MEDLINE - Academic Immunology Abstracts Toxicology Abstracts Environmental Sciences and Pollution Management AIDS and Cancer Research Abstracts PubMed Central (Full Participant titles) Unpaywall for CDI: Periodical Content Unpaywall Korean Citation Index |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic AIDS and Cancer Research Abstracts Immunology Abstracts Toxicology Abstracts Environmental Sciences and Pollution Management |
DatabaseTitleList | PubMed AIDS and Cancer Research Abstracts MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2092-7363 |
EndPage | 215 |
ExternalDocumentID | oai_kci_go_kr_ARTI_253225 10.4168/aair.2016.8.3.206 PMC4773208 26922930 10_4168_aair_2016_8_3_206 |
Genre | Journal Article |
GrantInformation_xml | – fundername: ; grantid: CRI13001-1 – fundername: ; grantid: 2013R1A1A2011845 – fundername: ; grantid: HI14C0187 |
GroupedDBID | --- 5-W 53G 8JR 8XY 9ZL AAKDD AAYXX ACPRK ADBBV ADRAZ AFRAH ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL CITATION C~G DIK DYU E3Z EF. F5P GX1 HYE KQ8 M48 O5R O5S OK1 PGMZT RPM NPM 7X8 7T5 7U7 C1K H94 5PM ADTOC UNPAY ACYCR |
ID | FETCH-LOGICAL-c465t-3c54068a44d1c58f727862b93cb92cd6d9736da0255ceead21cb06c04fccd8163 |
IEDL.DBID | M48 |
ISSN | 2092-7355 2092-7363 |
IngestDate | Sun Mar 09 07:50:35 EDT 2025 Tue Aug 19 23:49:17 EDT 2025 Thu Aug 21 14:10:52 EDT 2025 Fri Jul 11 05:54:11 EDT 2025 Wed Oct 01 13:59:02 EDT 2025 Thu Apr 03 06:57:39 EDT 2025 Wed Oct 01 02:16:38 EDT 2025 Thu Apr 24 22:51:52 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | Toll-like receptor 5 natural killer T cell flagellin Asthma |
Language | English |
License | http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. cc-by-nc |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c465t-3c54068a44d1c58f727862b93cb92cd6d9736da0255ceead21cb06c04fccd8163 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 G704-SER000002443.2016.8.3.001 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.4168/aair.2016.8.3.206 |
PMID | 26922930 |
PQID | 1769619620 |
PQPubID | 23479 |
PageCount | 10 |
ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_253225 unpaywall_primary_10_4168_aair_2016_8_3_206 pubmedcentral_primary_oai_pubmedcentral_nih_gov_4773208 proquest_miscellaneous_1837333932 proquest_miscellaneous_1769619620 pubmed_primary_26922930 crossref_primary_10_4168_aair_2016_8_3_206 crossref_citationtrail_10_4168_aair_2016_8_3_206 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2016-05-01 |
PublicationDateYYYYMMDD | 2016-05-01 |
PublicationDate_xml | – month: 05 year: 2016 text: 2016-05-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Korea (South) |
PublicationPlace_xml | – name: Korea (South) |
PublicationTitle | Allergy, asthma & immunology research |
PublicationTitleAlternate | Allergy Asthma Immunol Res |
PublicationYear | 2016 |
Publisher | The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease 대한천식알레르기학회 |
Publisher_xml | – name: The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease – name: 대한천식알레르기학회 |
References | Akbari (10.4168/aair.2016.8.3.206_ref9) 2006; 354 Lee (10.4168/aair.2016.8.3.206_ref15) 2008; 28 Akbari (10.4168/aair.2016.8.3.206_ref25) 2001; 2 La Cava (10.4168/aair.2016.8.3.206_ref31) 2006; 27 Moreira-Teixeira (10.4168/aair.2016.8.3.206_ref34) 2011; 186 Pichavant (10.4168/aair.2016.8.3.206_ref6) 2008; 205 Kupz (10.4168/aair.2016.8.3.206_ref39) 2014; 9 Engelmann (10.4168/aair.2016.8.3.206_ref35) 2011; 23 Koh (10.4168/aair.2016.8.3.206_ref11) 2010; 153 Shim (10.4168/aair.2016.8.3.206_ref19) 2012; 4 Nguyen (10.4168/aair.2016.8.3.206_ref20) 2013; 31 Kim (10.4168/aair.2016.8.3.206_ref30) 2014; 6 Kronenberg (10.4168/aair.2016.8.3.206_ref1) 2002; 2 Shim (10.4168/aair.2016.8.3.206_ref29) 2016; 137 Kim (10.4168/aair.2016.8.3.206_ref7) 2008; 14 Vijayanand (10.4168/aair.2016.8.3.206_ref10) 2007; 356 Thorburn (10.4168/aair.2016.8.3.206_ref33) 2012; 188 Terhorst (10.4168/aair.2016.8.3.206_ref37) 2007; 37 Moreno (10.4168/aair.2016.8.3.206_ref21) 2009; 1 Sag (10.4168/aair.2016.8.3.206_ref36) 2014; 124 Koh (10.4168/aair.2016.8.3.206_ref4) 2010; 161 Koh (10.4168/aair.2016.8.3.206_ref8) 2008; 181 Koh (10.4168/aair.2016.8.3.206_ref23) 2004; 19 Schülke (10.4168/aair.2016.8.3.206_ref17) 2011; 128 Li (10.4168/aair.2016.8.3.206_ref28) 2010; 42 Meyer (10.4168/aair.2016.8.3.206_ref5) 2006; 103 Umetsu (10.4168/aair.2016.8.3.206_ref2) 2006; 6 Koh (10.4168/aair.2016.8.3.206_ref12) 2012; 158 Monteiro (10.4168/aair.2016.8.3.206_ref22) 2010; 185 Lee (10.4168/aair.2016.8.3.206_ref16) 2006; 74 Huang (10.4168/aair.2016.8.3.206_ref27) 2010; 185 Schülke (10.4168/aair.2016.8.3.206_ref24) 2010; 48 Kearley (10.4168/aair.2016.8.3.206_ref26) 2005; 202 Azuma (10.4168/aair.2016.8.3.206_ref32) 2003; 63 Bates (10.4168/aair.2016.8.3.206_ref18) 2009; 182 Brennan (10.4168/aair.2016.8.3.206_ref14) 2013; 13 Akbari (10.4168/aair.2016.8.3.206_ref3) 2003; 9 Shim (10.4168/aair.2016.8.3.206_ref13) 2014; 6 Lun (10.4168/aair.2016.8.3.206_ref38) 2009; 29 18026856 - J Clin Immunol. 2008 Mar;28(2):157-65 21708895 - Int Immunol. 2011 Aug;23(8):473-84 19067129 - J Clin Immunol. 2009 May;29(3):330-42 20639482 - J Immunol. 2010 Aug 15;185(4):2157-63 16735139 - Trends Immunol. 2006 Jul;27(7):322-7 11477409 - Nat Immunol. 2001 Aug;2(8):725-31 18488036 - Nat Med. 2008 Jun;14(6):633-40 16314435 - J Exp Med. 2005 Dec 5;202(11):1539-47 12669034 - Nat Med. 2003 May;9(5):582-8 23334244 - Nat Rev Immunol. 2013 Feb;13(2):101-17 16540612 - N Engl J Med. 2006 Mar 16;354(11):1117-29 20965571 - Mol Immunol. 2010 Nov-Dec;48(1-3):341-50 19372244 - Am J Respir Cell Mol Biol. 2010 Feb;42(2):190-9 21478400 - J Immunol. 2011 May 15;186(10):5758-65 20456411 - Clin Exp Immunol. 2010 Jul 1;161(1):159-70 16369026 - Infect Immun. 2006 Jan;74(1):694-702 17068504 - Nat Rev Immunol. 2006 Dec;6(12):953-8 20635987 - Immunotherapy. 2009 Jul;1(4):557-70 16478801 - Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2782-7 12154375 - Nat Rev Immunol. 2002 Aug;2(8):557-68 22269676 - Int Arch Allergy Immunol. 2012;158(2):131-41 26303344 - J Allergy Clin Immunol. 2016 Feb;137(2):426-35 25229002 - Allergy Asthma Immunol Res. 2014 Sep;6(5):444-8 22950036 - Allergy Asthma Immunol Res. 2012 Sep;4(5):295-304 20484922 - Int Arch Allergy Immunol. 2010;153(3):239-48 24843794 - Allergy Asthma Immunol Res. 2014 May;6(3):201-7 18802058 - J Immunol. 2008 Oct 1;181(7):4560-9 19494277 - J Immunol. 2009 Jun 15;182(12):7539-47 12907625 - Cancer Res. 2003 Aug 1;63(15):4516-20 22461699 - J Immunol. 2012 May 1;188(9):4611-20 17359388 - Clin Exp Allergy. 2007 Mar;37(3):381-90 23831323 - Vaccine. 2013 Aug 20;31(37):3879-87 24827856 - PLoS One. 2014 May 14;9(5):e97418 21872305 - J Allergy Clin Immunol. 2011 Dec;128(6):1340-1348.e12 18250191 - J Exp Med. 2008 Feb 18;205(2):385-93 15483336 - J Korean Med Sci. 2004 Oct;19(5):640-6 25061873 - J Clin Invest. 2014 Sep;124(9):3725-40 20870943 - J Immunol. 2010 Nov 1;185(9):5003-10 17409322 - N Engl J Med. 2007 Apr 5;356(14):1410-22 |
References_xml | – volume: 128 start-page: 1340 year: 2011 ident: 10.4168/aair.2016.8.3.206_ref17 publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2011.07.036 – volume: 181 start-page: 4560 year: 2008 ident: 10.4168/aair.2016.8.3.206_ref8 publication-title: J Immunol doi: 10.4049/jimmunol.181.7.4560 – volume: 4 start-page: 295 year: 2012 ident: 10.4168/aair.2016.8.3.206_ref19 publication-title: Allergy Asthma Immunol Res doi: 10.4168/aair.2012.4.5.295 – volume: 202 start-page: 1539 year: 2005 ident: 10.4168/aair.2016.8.3.206_ref26 publication-title: J Exp Med doi: 10.1084/jem.20051166 – volume: 2 start-page: 557 year: 2002 ident: 10.4168/aair.2016.8.3.206_ref1 publication-title: Nat Rev Immunol doi: 10.1038/nri854 – volume: 6 start-page: 953 year: 2006 ident: 10.4168/aair.2016.8.3.206_ref2 publication-title: Nat Rev Immunol doi: 10.1038/nri1968 – volume: 205 start-page: 385 year: 2008 ident: 10.4168/aair.2016.8.3.206_ref6 publication-title: J Exp Med doi: 10.1084/jem.20071507 – volume: 124 start-page: 3725 year: 2014 ident: 10.4168/aair.2016.8.3.206_ref36 publication-title: J Clin Invest doi: 10.1172/JCI72308 – volume: 188 start-page: 4611 year: 2012 ident: 10.4168/aair.2016.8.3.206_ref33 publication-title: J Immunol doi: 10.4049/jimmunol.1101299 – volume: 29 start-page: 330 year: 2009 ident: 10.4168/aair.2016.8.3.206_ref38 publication-title: J Clin Immunol doi: 10.1007/s10875-008-9269-1 – volume: 354 start-page: 1117 year: 2006 ident: 10.4168/aair.2016.8.3.206_ref9 publication-title: N Engl J Med doi: 10.1056/NEJMoa053614 – volume: 6 start-page: 201 year: 2014 ident: 10.4168/aair.2016.8.3.206_ref30 publication-title: Allergy Asthma Immunol Res doi: 10.4168/aair.2014.6.3.201 – volume: 185 start-page: 2157 year: 2010 ident: 10.4168/aair.2016.8.3.206_ref22 publication-title: J Immunol doi: 10.4049/jimmunol.1000359 – volume: 161 start-page: 159 year: 2010 ident: 10.4168/aair.2016.8.3.206_ref4 publication-title: Clin Exp Immunol doi: 10.1111/j.1365-2249.2010.04151.x – volume: 2 start-page: 725 year: 2001 ident: 10.4168/aair.2016.8.3.206_ref25 publication-title: Nat Immunol doi: 10.1038/90667 – volume: 23 start-page: 473 year: 2011 ident: 10.4168/aair.2016.8.3.206_ref35 publication-title: Int Immunol doi: 10.1093/intimm/dxr040 – volume: 158 start-page: 131 year: 2012 ident: 10.4168/aair.2016.8.3.206_ref12 publication-title: Int Arch Allergy Immunol doi: 10.1159/000330908 – volume: 42 start-page: 190 year: 2010 ident: 10.4168/aair.2016.8.3.206_ref28 publication-title: Am J Respir Cell Mol Biol doi: 10.1165/rcmb.2009-0023OC – volume: 356 start-page: 1410 year: 2007 ident: 10.4168/aair.2016.8.3.206_ref10 publication-title: N Engl J Med doi: 10.1056/NEJMoa064691 – volume: 13 start-page: 101 year: 2013 ident: 10.4168/aair.2016.8.3.206_ref14 publication-title: Nat Rev Immunol doi: 10.1038/nri3369 – volume: 63 start-page: 4516 year: 2003 ident: 10.4168/aair.2016.8.3.206_ref32 publication-title: Cancer Res – volume: 48 start-page: 341 year: 2010 ident: 10.4168/aair.2016.8.3.206_ref24 publication-title: Mol Immunol doi: 10.1016/j.molimm.2010.07.006 – volume: 153 start-page: 239 year: 2010 ident: 10.4168/aair.2016.8.3.206_ref11 publication-title: Int Arch Allergy Immunol doi: 10.1159/000314364 – volume: 14 start-page: 633 year: 2008 ident: 10.4168/aair.2016.8.3.206_ref7 publication-title: Nat Med doi: 10.1038/nm1770 – volume: 137 start-page: 426 year: 2016 ident: 10.4168/aair.2016.8.3.206_ref29 publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2015.07.010 – volume: 9 start-page: e97418 year: 2014 ident: 10.4168/aair.2016.8.3.206_ref39 publication-title: PLoS One doi: 10.1371/journal.pone.0097418 – volume: 37 start-page: 381 year: 2007 ident: 10.4168/aair.2016.8.3.206_ref37 publication-title: Clin Exp Allergy doi: 10.1111/j.1365-2222.2006.02639.x – volume: 19 start-page: 640 year: 2004 ident: 10.4168/aair.2016.8.3.206_ref23 publication-title: J Korean Med Sci doi: 10.3346/jkms.2004.19.5.640 – volume: 9 start-page: 582 year: 2003 ident: 10.4168/aair.2016.8.3.206_ref3 publication-title: Nat Med doi: 10.1038/nm851 – volume: 6 start-page: 444 year: 2014 ident: 10.4168/aair.2016.8.3.206_ref13 publication-title: Allergy Asthma Immunol Res doi: 10.4168/aair.2014.6.5.444 – volume: 74 start-page: 694 year: 2006 ident: 10.4168/aair.2016.8.3.206_ref16 publication-title: Infect Immun doi: 10.1128/IAI.74.1.694-702.2006 – volume: 28 start-page: 157 year: 2008 ident: 10.4168/aair.2016.8.3.206_ref15 publication-title: J Clin Immunol doi: 10.1007/s10875-007-9138-3 – volume: 103 start-page: 2782 year: 2006 ident: 10.4168/aair.2016.8.3.206_ref5 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0510282103 – volume: 182 start-page: 7539 year: 2009 ident: 10.4168/aair.2016.8.3.206_ref18 publication-title: J Immunol doi: 10.4049/jimmunol.0804225 – volume: 1 start-page: 557 year: 2009 ident: 10.4168/aair.2016.8.3.206_ref21 publication-title: Immunotherapy doi: 10.2217/imt.09.30 – volume: 31 start-page: 3879 year: 2013 ident: 10.4168/aair.2016.8.3.206_ref20 publication-title: Vaccine doi: 10.1016/j.vaccine.2013.06.054 – volume: 185 start-page: 5003 year: 2010 ident: 10.4168/aair.2016.8.3.206_ref27 publication-title: J Immunol doi: 10.4049/jimmunol.0903446 – volume: 186 start-page: 5758 year: 2011 ident: 10.4168/aair.2016.8.3.206_ref34 publication-title: J Immunol doi: 10.4049/jimmunol.1003043 – volume: 27 start-page: 322 year: 2006 ident: 10.4168/aair.2016.8.3.206_ref31 publication-title: Trends Immunol doi: 10.1016/j.it.2006.05.003 – reference: 20456411 - Clin Exp Immunol. 2010 Jul 1;161(1):159-70 – reference: 12669034 - Nat Med. 2003 May;9(5):582-8 – reference: 20870943 - J Immunol. 2010 Nov 1;185(9):5003-10 – reference: 17359388 - Clin Exp Allergy. 2007 Mar;37(3):381-90 – reference: 21872305 - J Allergy Clin Immunol. 2011 Dec;128(6):1340-1348.e12 – reference: 24827856 - PLoS One. 2014 May 14;9(5):e97418 – reference: 17068504 - Nat Rev Immunol. 2006 Dec;6(12):953-8 – reference: 19067129 - J Clin Immunol. 2009 May;29(3):330-42 – reference: 16478801 - Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2782-7 – reference: 26303344 - J Allergy Clin Immunol. 2016 Feb;137(2):426-35 – reference: 18488036 - Nat Med. 2008 Jun;14(6):633-40 – reference: 22950036 - Allergy Asthma Immunol Res. 2012 Sep;4(5):295-304 – reference: 23831323 - Vaccine. 2013 Aug 20;31(37):3879-87 – reference: 11477409 - Nat Immunol. 2001 Aug;2(8):725-31 – reference: 21478400 - J Immunol. 2011 May 15;186(10):5758-65 – reference: 23334244 - Nat Rev Immunol. 2013 Feb;13(2):101-17 – reference: 24843794 - Allergy Asthma Immunol Res. 2014 May;6(3):201-7 – reference: 20635987 - Immunotherapy. 2009 Jul;1(4):557-70 – reference: 17409322 - N Engl J Med. 2007 Apr 5;356(14):1410-22 – reference: 18026856 - J Clin Immunol. 2008 Mar;28(2):157-65 – reference: 19494277 - J Immunol. 2009 Jun 15;182(12):7539-47 – reference: 20965571 - Mol Immunol. 2010 Nov-Dec;48(1-3):341-50 – reference: 16369026 - Infect Immun. 2006 Jan;74(1):694-702 – reference: 15483336 - J Korean Med Sci. 2004 Oct;19(5):640-6 – reference: 16735139 - Trends Immunol. 2006 Jul;27(7):322-7 – reference: 16314435 - J Exp Med. 2005 Dec 5;202(11):1539-47 – reference: 20639482 - J Immunol. 2010 Aug 15;185(4):2157-63 – reference: 25061873 - J Clin Invest. 2014 Sep;124(9):3725-40 – reference: 21708895 - Int Immunol. 2011 Aug;23(8):473-84 – reference: 25229002 - Allergy Asthma Immunol Res. 2014 Sep;6(5):444-8 – reference: 12154375 - Nat Rev Immunol. 2002 Aug;2(8):557-68 – reference: 16540612 - N Engl J Med. 2006 Mar 16;354(11):1117-29 – reference: 19372244 - Am J Respir Cell Mol Biol. 2010 Feb;42(2):190-9 – reference: 22461699 - J Immunol. 2012 May 1;188(9):4611-20 – reference: 18802058 - J Immunol. 2008 Oct 1;181(7):4560-9 – reference: 20484922 - Int Arch Allergy Immunol. 2010;153(3):239-48 – reference: 22269676 - Int Arch Allergy Immunol. 2012;158(2):131-41 – reference: 12907625 - Cancer Res. 2003 Aug 1;63(15):4516-20 – reference: 18250191 - J Exp Med. 2008 Feb 18;205(2):385-93 |
SSID | ssj0000314464 |
Score | 2.0714438 |
Snippet | Invariant natural killer T (iNKT) cells play a critical role in the pathogenesis of asthma. We previously reported the association between circulating Th2-like... PURPOSEInvariant natural killer T (iNKT) cells play a critical role in the pathogenesis of asthma. We previously reported the association between circulating... Purpose Invariant natural killer T (iNKT) cells play a critical role in the pathogenesis of asthma. We previously reported the association between circulating... Purpose: Invariant natural killer T (iNKT) cells play a critical role in the pathogenesis of asthma. We previously reported the association between circulating... |
SourceID | nrf unpaywall pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 206 |
SubjectTerms | Original 내과학 |
Title | Flagellin Modulates the Function of Invariant NKT Cells From Patients With Asthma via Dendritic Cells |
URI | https://www.ncbi.nlm.nih.gov/pubmed/26922930 https://www.proquest.com/docview/1769619620 https://www.proquest.com/docview/1837333932 https://pubmed.ncbi.nlm.nih.gov/PMC4773208 http://e-aair.org/Synapse/Data/PDFData/9999AAIR/aair-8-206.pdf https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002100524 |
UnpaywallVersion | publishedVersion |
Volume | 8 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Allergy, 2016, Asthma & Immunology Research, 8(3), , pp.206-215 |
journalDatabaseRights | – providerCode: PRVCAB databaseName: Nutrition and Food Sciences Database customDbUrl: eissn: 2092-7363 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000314464 issn: 2092-7363 databaseCode: DYU dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.cabidigitallibrary.org/product/zd providerName: CAB International – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 2092-7363 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000314464 issn: 2092-7363 databaseCode: KQ8 dateStart: 20090101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 2092-7363 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000314464 issn: 2092-7363 databaseCode: DIK dateStart: 20090101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 2092-7363 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000314464 issn: 2092-7363 databaseCode: GX1 dateStart: 0 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research – providerCode: PRVERR databaseName: KoreaMed Open Access customDbUrl: eissn: 2092-7363 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000314464 issn: 2092-7363 databaseCode: 5-W dateStart: 20090101 isFulltext: true titleUrlDefault: https://koreamed.org/journals providerName: Korean Association of Medical Journal Editors – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 2092-7363 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000314464 issn: 2092-7363 databaseCode: RPM dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVFZP databaseName: Scholars Portal Journals: Open Access customDbUrl: eissn: 2092-7363 dateEnd: 20250430 omitProxy: true ssIdentifier: ssj0000314464 issn: 2092-7363 databaseCode: M48 dateStart: 20091001 isFulltext: true titleUrlDefault: http://journals.scholarsportal.info providerName: Scholars Portal |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwELXaIgGXim9SoDISJ1AWJ3Yc54SqwqoFbcWhK8rJcuykGzVNSpIt9N8zs8muWLEqEqdYysRxMmPPe3LyhpA3zASxkmkOq5-JfZGJ0E9hfvvGChQoc1GY4__OkxN5NBWfz6KzLbIsbzW8wHYjtcN6UtOmHP36cfMBJjzg1xHACfXemAKVPQM5UiMODblN7kBiCjHIJwPaXyzMHMkP7jOHLAFcCam23-fc3AvqBMskhHzI1pLWdtXkm_Do359V3ptXV-bmpynLP3LW-AHZHcAmPeij4yHZyqpH5O5k2E5_TLJxCcsJqnLTSe2wkFfWUkCEdAzZDj1G65weV9fAp8EB9OTLKT0E85aOm_qSfu0lWVv6rehm9KDtZpeGXheGfswqt6ig0Fs_IdPxp9PDI3-ou-BbIaPO5xZgnFRGCBfYSOUAcYD3pAm3aRJaJ10Sc-kMshFIscaFgU2ZtEzk1joFAO8p2anqKntOaAAhoCSXKo-ssI4ZpmKXs9SIFKlQ7BG2fLHaDqLkWBuj1EBO0C0a3aLRLVppDg3pkberS656RY7bjF-Dt_SFLTTqaOPxvNYXjQa2cKzDCJczsFn6UsPcwg0TU2X1vNVBLBMgmDJkt9gAw-ecAwz2yLPe_6thLcPHI_FaZKwMcEzrZ6pittD4FnHMQ6Y88m4VQ_9-2r3_vs8Lch876r_kfEl2umaevQK01aX7wDO-T_cXM-k3keEnzw |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Flagellin+Modulates+the+Function+of+Invariant+NKT+Cells+From+Patients+With+Asthma+via+Dendritic+Cells&rft.jtitle=Allergy%2C+asthma+%26+immunology+research&rft.au=Shim%2C+Jae-Uoong&rft.au=Rhee%2C+Joon-Haeng&rft.au=Jeong%2C+Ji-Ung&rft.au=Koh%2C+Young-Il&rft.date=2016-05-01&rft.pub=The+Korean+Academy+of+Asthma%2C+Allergy+and+Clinical+Immunology%3B+The+Korean+Academy+of+Pediatric+Allergy+and+Respiratory+Disease&rft.issn=2092-7355&rft.eissn=2092-7363&rft.volume=8&rft.issue=3&rft.spage=206&rft.epage=215&rft_id=info:doi/10.4168%2Faair.2016.8.3.206&rft_id=info%3Apmid%2F26922930&rft.externalDocID=PMC4773208 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2092-7355&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2092-7355&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2092-7355&client=summon |